Follow the instructions of your provider and keep to your appointments
While semaglutide can be effective for weight loss, it may have side effects
In the ATTAIN-MAINTAIN trial, orforglipron's profile was "consistent with previous orforglipron Phase 3 studies." The most common adverse events were gastrointestinal-related and were generally mild-to-moderate in severity, which is expected for the GLP-1 class
While earlier medications targeted single pathways, this compound simultaneously activates three distinct receptor systems that work together to produce unprecedented fat loss results
[25] The GLP-1 receptor agonist should not be restarted, and alternative weight management strategies should be considered once recovery is complete
Many GLP-1 users prioritize supplements that support protein intake, digestion, and micronutrient coverage